Skip to main content

Advertisement

Table 1 Patient demographics

From: Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer

Patient no. Age (years) Tumor size (mm) Node status ER status PgR status Clinical response Pathological finding (after chemotherapy)
1 42 7 + + n/a CR No surgery
2 37 50 + + n/a MRD No surgery
3 50 19 + + n/a MRD DCIS only
4 56 24 - - n/a MRD No surgery
5 56 50 + - n/a MRD DCIS only
6 48 50 + - n/a SD RID
7 64 40 + - - PR RID
8 47 30 - + n/a SD RID
9 51 50 - + n/a PR RID
10 67 30 - - - SD RID
  1. CR, complete clinical response (no residual palpable disease); ER, estrogen receptor; MRD, minimal residual disease (residual palpable irregularity that was too small to be measured); n/a, not available; PgR, progestrogen receptor; PR, partial response (more than 50% reduction in bidimensional measurement); SD, stable disease (between 50% reduction and 25% increase in bidimensional measurement); RID, residual invasive disease; DCIS, ductal carcinoma in situ.